SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017...

37
SEER Cancer Statistics Review 1975-2017 National Cancer Institute Joinpoint Regression Program Version 4.8, April 2020, National Cancer Institute. (https://surveillance.cancer.gov/joinpoint/). The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130). a Trends are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). b Trends are from the SEER 21 areas (SEER 9 areas, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts). c Trends are from US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention. d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint. e API - Asian/Pacific Islander, AI/AN - American Indian/Alaska Native, NH - Non-Hispanic f Hispanic and Non-Hispanic are not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registry. g Data for American Indian/Alaska Native are based on the Purchased/Referred Care Delivery Area (PRCDA) counties. * The APC/AAPC is significantly different from zero (p<.05). - Joinpoint regression line analysis could not be performed on data series. JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPC d Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17 SEER 9 Delay-Adjusted Incidence a , 1975-2017 All Races 1975-82 2.5* 1982-91 1.0* 1991-07 -0.7* 2007-17 -2.1* -2.1* -2.1* White 1975-82 2.5* 1982-91 1.1* 1991-07 -0.6* 2007-17 -2.0* -2.0* -2.0* Black 1975-84 3.5* 1984-03 -0.6* 2003-17 -2.4* -2.4* -2.4* SEER 21 Delay-Adjusted Incidence b , 2000-2017 All Races 2000-08 -0.7* 2008-11 -2.7* 2011-17 -1.7* -2.0* -1.7* White 2000-08 -0.6* 2008-11 -2.7* 2011-17 -1.7* -2.0* -1.7* White NH ef 2000-08 -0.5* 2008-11 -2.5* 2011-17 -1.4* -1.8* -1.4* Black 2000-09 -1.2* 2009-17 -2.5* -2.4* -2.5* Black NH ef 2000-09 -1.1* 2009-17 -2.6* -2.4* -2.6* API e 2000-17 -0.7* -0.7* -0.7* AI/AN eg 2000-17 -1.1* -1.1* -1.1* Hispanic f 2000-07 -0.6 2007-17 -1.9* -1.9* -1.9* U.S. Cancer Mortality c , 1975-2017 All Races 1975-80 3.0* 1980-90 1.8* 1990-95 -0.2 1995-05 -1.0* 2005-14 -2.4* 2014-17 -4.9* -3.3* -4.3* White 1975-80 2.9* 1980-90 1.8* 1990-95 -0.1 1995-06 -0.9* 2006-14 -2.5* 2014-17 -4.6* -3.2* -4.1* Black 1975-81 3.5* 1981-90 1.9* 1990-95 -0.7* 1995-04 -1.7* 2004-13 -2.7* 2013-17 -5.1* -3.7* -5.1* U.S. Cancer Mortality c , 2000-2017 All Races 2000-05 -1.1* 2005-10 -2.2* 2010-14 -2.8* 2014-17 -4.6* -3.3* -4.2* White 2000-05 -1.0* 2005-10 -2.0* 2010-15 -2.9* 2015-17 -5.2* -3.2* -4.0* White NH ef 2000-05 -0.9* 2005-10 -1.9* 2010-15 -2.8* 2015-17 -4.9* -3.1* -3.9* Black 2000-04 -1.6* 2004-13 -2.7* 2013-17 -5.1* -3.7* -5.1* Black NH ef 2000-05 -1.5* 2005-08 -3.2* 2008-13 -2.3* 2013-17 -5.2* -3.6* -5.2* API e 2000-13 -1.3* 2013-17 -3.4* -2.2* -3.4* AI/AN eg 2000-08 0.6 2008-17 -3.1* -3.1* -3.1* Hispanic f 2000-15 -2.2* 2015-17 -7.0* -3.3* -4.6* Table 15.1 Cancer of the Lung and Bronchus (Invasive) Trends in SEER Incidence ab and U.S. Mortality c Using the Joinpoint Regression Program, 1975-2017 With up to Five Joinpoints, 2000-2017 With up to Three Joinpoints, Both Sexes by Race/Ethnicity

Transcript of SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017...

Page 1: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 25 1982-91 10 1991-07 -07 2007-17 -21 -21 -21

White 1975-82 25 1982-91 11 1991-07 -06 2007-17 -20 -20 -20

Black 1975-84 35 1984-03 -06 2003-17 -24 -24 -24

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-08 -07 2008-11 -27 2011-17 -17 -20 -17

White 2000-08 -06 2008-11 -27 2011-17 -17 -20 -17

White NHef 2000-08 -05 2008-11 -25 2011-17 -14 -18 -14

Black 2000-09 -12 2009-17 -25 -24 -25

Black NHef 2000-09 -11 2009-17 -26 -24 -26

APIe 2000-17 -07 -07 -07

AIANeg 2000-17 -11 -11 -11

Hispanicf 2000-07 -06 2007-17 -19 -19 -19

US Cancer Mortalityc 1975-2017

All Races 1975-80 30 1980-90 18 1990-95 -02 1995-05 -10 2005-14 -24 2014-17 -49 -33 -43

White 1975-80 29 1980-90 18 1990-95 -01 1995-06 -09 2006-14 -25 2014-17 -46 -32 -41

Black 1975-81 35 1981-90 19 1990-95 -07 1995-04 -17 2004-13 -27 2013-17 -51 -37 -51

US Cancer Mortalityc 2000-2017

All Races 2000-05 -11 2005-10 -22 2010-14 -28 2014-17 -46 -33 -42

White 2000-05 -10 2005-10 -20 2010-15 -29 2015-17 -52 -32 -40

White NHef 2000-05 -09 2005-10 -19 2010-15 -28 2015-17 -49 -31 -39

Black 2000-04 -16 2004-13 -27 2013-17 -51 -37 -51

Black NHef 2000-05 -15 2005-08 -32 2008-13 -23 2013-17 -52 -36 -52

APIe 2000-13 -13 2013-17 -34 -22 -34

AIANeg 2000-08 06 2008-17 -31 -31 -31

Hispanicf 2000-15 -22 2015-17 -70 -33 -46

Table 151

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Both Sexes by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 15 1982-91 -05 1991-07 -17 2007-17 -26 -26 -26

White 1975-81 14 1981-89 -01 1989-07 -16 2007-17 -26 -26 -26

Black 1975-84 29 1984-98 -14 1998-17 -29 -29 -29

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-09 -18 2009-12 -35 2012-17 -23 -27 -23

White 2000-08 -16 2008-17 -28 -28 -28

White NHef 2000-09 -15 2009-12 -33 2012-17 -21 -24 -21

Black 2000-17 -28 -28 -28

Black NHef 2000-17 -27 -27 -27

APIe 2000-17 -14 -14 -14

AIANeg 2000-17 -16 -16 -16

Hispanicf 2000-17 -24 -24 -24

US Cancer Mortalityc 1975-2017

All Races 1975-78 24 1978-84 12 1984-91 03 1991-05 -19 2005-13 -30 2013-17 -48 -38 -48

White 1975-82 17 1982-91 04 1991-05 -18 2005-13 -29 2013-17 -47 -37 -47

Black 1975-81 31 1981-89 16 1989-93 -06 1993-02 -26 2002-13 -34 2013-17 -57 -44 -57

US Cancer Mortalityc 2000-2017

All Races 2000-05 -20 2005-12 -29 2012-15 -40 2015-17 -56 -39 -48

White 2000-05 -18 2005-11 -28 2011-15 -37 2015-17 -56 -38 -46

White NHef 2000-05 -17 2005-10 -26 2010-14 -32 2014-17 -48 -36 -45

Black 2000-13 -33 2013-17 -58 -44 -58

Black NHef 2000-13 -32 2013-17 -58 -43 -58

APIe 2000-08 -13 2008-17 -29 -29 -29

AIANeg 2000-08 06 2008-17 -36 -36 -36

Hispanicf 2000-15 -30 2015-17 -75 -40 -53

Table 152

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Males by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 56 1982-91 34 1991-06 05 2006-17 -14 -14 -14

White 1975-88 48 1988-97 14 1997-07 02 2007-17 -14 -14 -14

Black 1975-90 42 1990-06 07 2006-17 -19 -19 -19

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-08 02 2008-11 -23 2011-17 -10 -14 -10

White 2000-08 03 2008-11 -23 2011-17 -09 -14 -09

White NHef 2000-08 05 2008-11 -21 2011-17 -07 -12 -07

Black 2000-09 03 2009-17 -20 -17 -20

Black NHef 2000-09 03 2009-17 -20 -17 -20

APIe 2000-17 03 03 03

AIANeg 2000-17 -06 -06 -06

Hispanicf 2000-17 -03 -03 -03

US Cancer Mortalityc 1975-2017

All Races 1975-82 60 1982-90 42 1990-95 18 1995-05 02 2005-14 -18 2014-17 -44 -27 -37

White 1975-83 59 1983-92 38 1992-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

Black 1975-82 63 1982-92 37 1992-04 03 2004-13 -19 2013-17 -45 -31 -45

US Cancer Mortalityc 2000-2017

All Races 2000-02 06 2002-07 -07 2007-14 -20 2014-17 -42 -27 -37

White 2000-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

White NHef 2000-02 07 2002-07 -04 2007-14 -18 2014-17 -39 -25 -33

Black 2000-04 06 2004-13 -18 2013-17 -45 -31 -45

Black NHef 2000-05 05 2005-08 -28 2008-13 -14 2013-17 -47 -29 -47

APIe 2000-14 -04 2014-17 -46 -18 -35

AIANeg 2000-04 40 2004-17 -21 -21 -21

Hispanicf 2000-15 -10 2015-17 -64 -22 -37

Table 153

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Females by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052

8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2013-17

SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2017

All Races Both Sexes 1975-82 62 1982-89 11 1989-07 -23 2007-17 -30 -30

All Races Male 1975-81 56 1981-88 00 1988-17 -31 -31

All Races Female 1975-82 95 1982-90 33 1990-04 -14 2004-17 -26 -26

White Both Sexes 1975-82 64 1982-89 13 1989-07 -21 2007-17 -30 -30

White Male 1975-78 88 1978-86 21 1986-17 -30 -30

White Female 1975-82 100 1982-90 34 1990-06 -12 2006-17 -26 -26

Black Both Sexes 1975-86 49 1986-17 -25 -25

Black Male 1975-85 50 1985-17 -34 -34

Black Female 1975-91 46 1991-17 -19 -19

SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2017

All Races Both Sexes 1975-80 52 1980-88 17 1988-00 -09 2000-03 62 2003-17 -17 -17

All Races Male 1975-84 29 1984-00 -17 2000-03 47 2003-17 -25 -25

All Races Female 1975-78 102 1978-88 47 1988-99 06 1999-05 38 2005-17 -12 -12

White Both Sexes 1975-79 61 1979-88 19 1988-00 -08 2000-03 61 2003-17 -17 -17

White Male 1975-80 44 1980-88 05 1988-99 -23 1999-02 54 2002-17 -23 -23

White Female 1975-78 104 1978-88 49 1988-00 07 2000-03 71 2003-17 -09 -09

Black Both Sexes 1975-84 45 1984-00 -12 2000-03 58 2003-17 -24 -24

Black Male 1975-84 39 1984-00 -22 2000-03 42 2003-17 -32 -32

Black Female 1975-90 50 1990-97 -15 1997-05 41 2005-17 -19 -19

Table 154

Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints

By Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 6002 7071 5230 6072 6980 5416 7434 9811 58692010 5778 6805 5016 5896 6798 5220 6718 8565 55022011 5633 6577 4940 5735 6545 5140 6585 8644 52492012 5537 6413 4885 5582 6306 5047 6965 8944 56282013 5424 6188 4858 5494 6098 5048 6401 8201 51982014 5336 6035 4820 5478 6045 5068 6037 7507 50672015 5212 5911 4687 5304 5840 4904 6047 7665 49812016 5160 5872 4624 5238 5781 4835 5947 7577 48052017 5056 5669 4604 5145 5606 4811 5771 7328 4762

Table 155Cancer of the Lung and Bronchus (Invasive)

Delay-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 2: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 15 1982-91 -05 1991-07 -17 2007-17 -26 -26 -26

White 1975-81 14 1981-89 -01 1989-07 -16 2007-17 -26 -26 -26

Black 1975-84 29 1984-98 -14 1998-17 -29 -29 -29

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-09 -18 2009-12 -35 2012-17 -23 -27 -23

White 2000-08 -16 2008-17 -28 -28 -28

White NHef 2000-09 -15 2009-12 -33 2012-17 -21 -24 -21

Black 2000-17 -28 -28 -28

Black NHef 2000-17 -27 -27 -27

APIe 2000-17 -14 -14 -14

AIANeg 2000-17 -16 -16 -16

Hispanicf 2000-17 -24 -24 -24

US Cancer Mortalityc 1975-2017

All Races 1975-78 24 1978-84 12 1984-91 03 1991-05 -19 2005-13 -30 2013-17 -48 -38 -48

White 1975-82 17 1982-91 04 1991-05 -18 2005-13 -29 2013-17 -47 -37 -47

Black 1975-81 31 1981-89 16 1989-93 -06 1993-02 -26 2002-13 -34 2013-17 -57 -44 -57

US Cancer Mortalityc 2000-2017

All Races 2000-05 -20 2005-12 -29 2012-15 -40 2015-17 -56 -39 -48

White 2000-05 -18 2005-11 -28 2011-15 -37 2015-17 -56 -38 -46

White NHef 2000-05 -17 2005-10 -26 2010-14 -32 2014-17 -48 -36 -45

Black 2000-13 -33 2013-17 -58 -44 -58

Black NHef 2000-13 -32 2013-17 -58 -43 -58

APIe 2000-08 -13 2008-17 -29 -29 -29

AIANeg 2000-08 06 2008-17 -36 -36 -36

Hispanicf 2000-15 -30 2015-17 -75 -40 -53

Table 152

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Males by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 56 1982-91 34 1991-06 05 2006-17 -14 -14 -14

White 1975-88 48 1988-97 14 1997-07 02 2007-17 -14 -14 -14

Black 1975-90 42 1990-06 07 2006-17 -19 -19 -19

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-08 02 2008-11 -23 2011-17 -10 -14 -10

White 2000-08 03 2008-11 -23 2011-17 -09 -14 -09

White NHef 2000-08 05 2008-11 -21 2011-17 -07 -12 -07

Black 2000-09 03 2009-17 -20 -17 -20

Black NHef 2000-09 03 2009-17 -20 -17 -20

APIe 2000-17 03 03 03

AIANeg 2000-17 -06 -06 -06

Hispanicf 2000-17 -03 -03 -03

US Cancer Mortalityc 1975-2017

All Races 1975-82 60 1982-90 42 1990-95 18 1995-05 02 2005-14 -18 2014-17 -44 -27 -37

White 1975-83 59 1983-92 38 1992-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

Black 1975-82 63 1982-92 37 1992-04 03 2004-13 -19 2013-17 -45 -31 -45

US Cancer Mortalityc 2000-2017

All Races 2000-02 06 2002-07 -07 2007-14 -20 2014-17 -42 -27 -37

White 2000-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

White NHef 2000-02 07 2002-07 -04 2007-14 -18 2014-17 -39 -25 -33

Black 2000-04 06 2004-13 -18 2013-17 -45 -31 -45

Black NHef 2000-05 05 2005-08 -28 2008-13 -14 2013-17 -47 -29 -47

APIe 2000-14 -04 2014-17 -46 -18 -35

AIANeg 2000-04 40 2004-17 -21 -21 -21

Hispanicf 2000-15 -10 2015-17 -64 -22 -37

Table 153

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Females by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052

8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2013-17

SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2017

All Races Both Sexes 1975-82 62 1982-89 11 1989-07 -23 2007-17 -30 -30

All Races Male 1975-81 56 1981-88 00 1988-17 -31 -31

All Races Female 1975-82 95 1982-90 33 1990-04 -14 2004-17 -26 -26

White Both Sexes 1975-82 64 1982-89 13 1989-07 -21 2007-17 -30 -30

White Male 1975-78 88 1978-86 21 1986-17 -30 -30

White Female 1975-82 100 1982-90 34 1990-06 -12 2006-17 -26 -26

Black Both Sexes 1975-86 49 1986-17 -25 -25

Black Male 1975-85 50 1985-17 -34 -34

Black Female 1975-91 46 1991-17 -19 -19

SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2017

All Races Both Sexes 1975-80 52 1980-88 17 1988-00 -09 2000-03 62 2003-17 -17 -17

All Races Male 1975-84 29 1984-00 -17 2000-03 47 2003-17 -25 -25

All Races Female 1975-78 102 1978-88 47 1988-99 06 1999-05 38 2005-17 -12 -12

White Both Sexes 1975-79 61 1979-88 19 1988-00 -08 2000-03 61 2003-17 -17 -17

White Male 1975-80 44 1980-88 05 1988-99 -23 1999-02 54 2002-17 -23 -23

White Female 1975-78 104 1978-88 49 1988-00 07 2000-03 71 2003-17 -09 -09

Black Both Sexes 1975-84 45 1984-00 -12 2000-03 58 2003-17 -24 -24

Black Male 1975-84 39 1984-00 -22 2000-03 42 2003-17 -32 -32

Black Female 1975-90 50 1990-97 -15 1997-05 41 2005-17 -19 -19

Table 154

Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints

By Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 6002 7071 5230 6072 6980 5416 7434 9811 58692010 5778 6805 5016 5896 6798 5220 6718 8565 55022011 5633 6577 4940 5735 6545 5140 6585 8644 52492012 5537 6413 4885 5582 6306 5047 6965 8944 56282013 5424 6188 4858 5494 6098 5048 6401 8201 51982014 5336 6035 4820 5478 6045 5068 6037 7507 50672015 5212 5911 4687 5304 5840 4904 6047 7665 49812016 5160 5872 4624 5238 5781 4835 5947 7577 48052017 5056 5669 4604 5145 5606 4811 5771 7328 4762

Table 155Cancer of the Lung and Bronchus (Invasive)

Delay-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 3: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding

SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska

Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2008-17 2013-17

SEER 9 Delay-Adjusted Incidencea 1975-2017

All Races 1975-82 56 1982-91 34 1991-06 05 2006-17 -14 -14 -14

White 1975-88 48 1988-97 14 1997-07 02 2007-17 -14 -14 -14

Black 1975-90 42 1990-06 07 2006-17 -19 -19 -19

SEER 21 Delay-Adjusted Incidenceb 2000-2017

All Races 2000-08 02 2008-11 -23 2011-17 -10 -14 -10

White 2000-08 03 2008-11 -23 2011-17 -09 -14 -09

White NHef 2000-08 05 2008-11 -21 2011-17 -07 -12 -07

Black 2000-09 03 2009-17 -20 -17 -20

Black NHef 2000-09 03 2009-17 -20 -17 -20

APIe 2000-17 03 03 03

AIANeg 2000-17 -06 -06 -06

Hispanicf 2000-17 -03 -03 -03

US Cancer Mortalityc 1975-2017

All Races 1975-82 60 1982-90 42 1990-95 18 1995-05 02 2005-14 -18 2014-17 -44 -27 -37

White 1975-83 59 1983-92 38 1992-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

Black 1975-82 63 1982-92 37 1992-04 03 2004-13 -19 2013-17 -45 -31 -45

US Cancer Mortalityc 2000-2017

All Races 2000-02 06 2002-07 -07 2007-14 -20 2014-17 -42 -27 -37

White 2000-02 06 2002-07 -06 2007-14 -19 2014-17 -40 -26 -35

White NHef 2000-02 07 2002-07 -04 2007-14 -18 2014-17 -39 -25 -33

Black 2000-04 06 2004-13 -18 2013-17 -45 -31 -45

Black NHef 2000-05 05 2005-08 -28 2008-13 -14 2013-17 -47 -29 -47

APIe 2000-14 -04 2014-17 -46 -18 -35

AIANeg 2000-04 40 2004-17 -21 -21 -21

Hispanicf 2000-15 -10 2015-17 -64 -22 -37

Table 153

Cancer of the Lung and Bronchus (Invasive)

Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints 2000-2017 With up to Three Joinpoints

Females by RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052

8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2013-17

SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2017

All Races Both Sexes 1975-82 62 1982-89 11 1989-07 -23 2007-17 -30 -30

All Races Male 1975-81 56 1981-88 00 1988-17 -31 -31

All Races Female 1975-82 95 1982-90 33 1990-04 -14 2004-17 -26 -26

White Both Sexes 1975-82 64 1982-89 13 1989-07 -21 2007-17 -30 -30

White Male 1975-78 88 1978-86 21 1986-17 -30 -30

White Female 1975-82 100 1982-90 34 1990-06 -12 2006-17 -26 -26

Black Both Sexes 1975-86 49 1986-17 -25 -25

Black Male 1975-85 50 1985-17 -34 -34

Black Female 1975-91 46 1991-17 -19 -19

SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2017

All Races Both Sexes 1975-80 52 1980-88 17 1988-00 -09 2000-03 62 2003-17 -17 -17

All Races Male 1975-84 29 1984-00 -17 2000-03 47 2003-17 -25 -25

All Races Female 1975-78 102 1978-88 47 1988-99 06 1999-05 38 2005-17 -12 -12

White Both Sexes 1975-79 61 1979-88 19 1988-00 -08 2000-03 61 2003-17 -17 -17

White Male 1975-80 44 1980-88 05 1988-99 -23 1999-02 54 2002-17 -23 -23

White Female 1975-78 104 1978-88 49 1988-00 07 2000-03 71 2003-17 -09 -09

Black Both Sexes 1975-84 45 1984-00 -12 2000-03 58 2003-17 -24 -24

Black Male 1975-84 39 1984-00 -22 2000-03 42 2003-17 -32 -32

Black Female 1975-90 50 1990-97 -15 1997-05 41 2005-17 -19 -19

Table 154

Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints

By Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 6002 7071 5230 6072 6980 5416 7434 9811 58692010 5778 6805 5016 5896 6798 5220 6718 8565 55022011 5633 6577 4940 5735 6545 5140 6585 8644 52492012 5537 6413 4885 5582 6306 5047 6965 8944 56282013 5424 6188 4858 5494 6098 5048 6401 8201 51982014 5336 6035 4820 5478 6045 5068 6037 7507 50672015 5212 5911 4687 5304 5840 4904 6047 7665 49812016 5160 5872 4624 5238 5781 4835 5947 7577 48052017 5056 5669 4604 5145 5606 4811 5771 7328 4762

Table 155Cancer of the Lung and Bronchus (Invasive)

Delay-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 4: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Regression Program Version 48 April 2020 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052

8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series

JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd

Years APC Years APC Years APC Years APC Years APC Years APC 2013-17

SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2017

All Races Both Sexes 1975-82 62 1982-89 11 1989-07 -23 2007-17 -30 -30

All Races Male 1975-81 56 1981-88 00 1988-17 -31 -31

All Races Female 1975-82 95 1982-90 33 1990-04 -14 2004-17 -26 -26

White Both Sexes 1975-82 64 1982-89 13 1989-07 -21 2007-17 -30 -30

White Male 1975-78 88 1978-86 21 1986-17 -30 -30

White Female 1975-82 100 1982-90 34 1990-06 -12 2006-17 -26 -26

Black Both Sexes 1975-86 49 1986-17 -25 -25

Black Male 1975-85 50 1985-17 -34 -34

Black Female 1975-91 46 1991-17 -19 -19

SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2017

All Races Both Sexes 1975-80 52 1980-88 17 1988-00 -09 2000-03 62 2003-17 -17 -17

All Races Male 1975-84 29 1984-00 -17 2000-03 47 2003-17 -25 -25

All Races Female 1975-78 102 1978-88 47 1988-99 06 1999-05 38 2005-17 -12 -12

White Both Sexes 1975-79 61 1979-88 19 1988-00 -08 2000-03 61 2003-17 -17 -17

White Male 1975-80 44 1980-88 05 1988-99 -23 1999-02 54 2002-17 -23 -23

White Female 1975-78 104 1978-88 49 1988-00 07 2000-03 71 2003-17 -09 -09

Black Both Sexes 1975-84 45 1984-00 -12 2000-03 58 2003-17 -24 -24

Black Male 1975-84 39 1984-00 -22 2000-03 42 2003-17 -32 -32

Black Female 1975-90 50 1990-97 -15 1997-05 41 2005-17 -19 -19

Table 154

Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program

1975-2017 With up to Five Joinpoints

By Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 6002 7071 5230 6072 6980 5416 7434 9811 58692010 5778 6805 5016 5896 6798 5220 6718 8565 55022011 5633 6577 4940 5735 6545 5140 6585 8644 52492012 5537 6413 4885 5582 6306 5047 6965 8944 56282013 5424 6188 4858 5494 6098 5048 6401 8201 51982014 5336 6035 4820 5478 6045 5068 6037 7507 50672015 5212 5911 4687 5304 5840 4904 6047 7665 49812016 5160 5872 4624 5238 5781 4835 5947 7577 48052017 5056 5669 4604 5145 5606 4811 5771 7328 4762

Table 155Cancer of the Lung and Bronchus (Invasive)

Delay-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 5: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 6002 7071 5230 6072 6980 5416 7434 9811 58692010 5778 6805 5016 5896 6798 5220 6718 8565 55022011 5633 6577 4940 5735 6545 5140 6585 8644 52492012 5537 6413 4885 5582 6306 5047 6965 8944 56282013 5424 6188 4858 5494 6098 5048 6401 8201 51982014 5336 6035 4820 5478 6045 5068 6037 7507 50672015 5212 5911 4687 5304 5840 4904 6047 7665 49812016 5160 5872 4624 5238 5781 4835 5947 7577 48052017 5056 5669 4604 5145 5606 4811 5771 7328 4762

Table 155Cancer of the Lung and Bronchus (Invasive)

Delay-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 6: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 6121 8145 4627 6164 8094 4748 7591 11205 50791975-1979 5622 9432 2833 5560 9359 2839 7201 12585 30721980 6065 9997 3220 5942 9770 3235 8662 15143 38251981 6203 9941 3511 6153 9844 3552 8231 14296 37451982 6329 10069 3673 6305 9968 3768 8037 14106 35681983 6345 9946 3788 6303 9763 3909 8662 15134 39491984 6549 10205 3945 6433 9989 3961 9293 15884 44821985 6461 9862 4023 6397 9687 4085 8956 14968 46041986 6577 9903 4229 6513 9731 4294 9294 15627 48671987 6790 10151 4416 6808 10066 4549 8476 14359 43281988 6806 9870 4634 6826 9792 4773 8824 14493 48261989 6756 9796 4613 6757 9706 4726 8911 14277 51491990 6808 9692 4778 6823 9612 4895 8678 13717 52131991 6919 9721 4957 6896 9589 5061 9312 14476 57021992 6946 9721 4985 6892 9490 5104 9399 14873 56061993 6775 9395 4915 6780 9251 5063 8636 13535 52541994 6717 9093 5054 6728 9013 5161 8716 13139 56531995 6685 8982 5044 6710 8795 5245 8587 13894 50121996 6646 8797 5124 6679 8667 5297 8456 12832 55731997 6663 8631 5259 6719 8481 5492 8227 12954 50491998 6755 8803 5298 6800 8659 5502 8752 13087 58301999 6583 8457 5250 6629 8325 5442 8456 12246 58852000 6414 8212 5122 6466 8078 5322 8071 11516 57752001 6416 8141 5167 6506 8109 5350 8063 11451 57822002 6406 8044 5250 6479 7985 5423 8148 11310 60712003 6477 8105 5310 6551 7956 5565 8120 11940 55812004 6224 7629 5206 6279 7529 5377 7621 10542 57022005 6303 7582 5384 6400 7553 5579 7473 9797 59552006 6230 7430 5346 6283 7310 5534 7675 10110 59962007 6210 7377 5357 6312 7289 5603 7419 10068 56642008 6039 7214 5187 6113 7072 5430 7504 10338 56162009 5999 7067 5227 6069 6976 5413 7427 9801 58632010 5773 6798 5011 5890 6791 5215 6704 8548 54922011 5625 6567 4933 5726 6534 5132 6567 8619 52352012 5526 6400 4876 5570 6292 5036 6938 8908 56072013 5411 6172 4846 5479 6082 5034 6372 8163 51742014 5320 6017 4806 5461 6025 5052 6001 7461 50372015 5186 5881 4664 5276 5808 4878 6001 7606 49432016 5114 5819 4584 5189 5726 4790 5875 7483 47482017 4945 5543 4505 5024 5471 4700 5612 7120 4633

Table 156Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 7: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 836 1037 684 887 1081 742 786 1061 5931975-1979 777 1214 447 797 1249 461 757 1177 4351980 911 1420 525 934 1440 556 999 1753 4381981 974 1459 613 1003 1487 648 928 1587 4341982 1044 1500 717 1081 1536 762 969 1608 4921983 1039 1492 710 1078 1509 766 923 1520 4951984 1071 1524 741 1107 1571 776 1041 1499 6861985 1047 1500 710 1081 1528 752 1112 1790 6271986 1122 1557 798 1157 1605 827 1226 1770 8351987 1067 1415 822 1118 1457 886 968 1461 6201988 1138 1528 853 1191 1562 923 1049 1786 5301989 1127 1486 871 1171 1525 923 1214 1767 8471990 1067 1386 840 1128 1449 906 935 1370 6211991 1131 1399 939 1171 1432 988 1234 1592 10001992 1051 1341 845 1097 1385 896 1022 1332 8051993 1003 1234 834 1048 1264 894 943 1336 6741994 977 1169 842 1024 1197 905 995 1353 7501995 987 1230 812 1037 1264 873 950 1389 6611996 973 1209 798 1029 1249 864 880 1202 6841997 953 1086 864 1011 1112 948 786 1082 6051998 929 1086 814 986 1128 882 950 1226 7551999 882 1006 797 933 1025 878 825 1121 6052000 880 1046 759 928 1085 813 959 1180 8022001 837 986 733 891 1035 793 857 1091 6892002 829 939 754 898 986 839 721 980 5712003 822 912 760 873 938 833 793 950 6832004 812 900 749 852 925 800 864 1008 7752005 759 869 682 822 924 751 663 778 5882006 769 853 708 826 885 786 683 819 5892007 768 860 702 833 896 792 710 940 5442008 709 796 646 759 812 720 638 885 4872009 713 778 668 760 812 726 756 836 7022010 681 749 634 746 798 713 589 688 5152011 628 686 586 677 710 656 528 644 4492012 646 720 589 694 755 646 664 831 5622013 635 713 580 689 750 647 551 677 4742014 603 636 581 656 664 657 584 658 5292015 593 625 571 642 654 638 578 628 5382016 555 611 514 586 617 566 574 633 5232017 553 587 530 594 603 591 503 599 446

Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)

Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 8: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Diagnosis1975-2017 4219 5603 3181 4198 5506 3222 5485 8090 36491975-1979 3457 5732 1736 3374 5599 1726 4845 8622 19141980 3934 6433 2068 3813 6217 2054 5912 10314 25801981 4054 6479 2259 4000 6385 2268 5497 9467 24971982 4141 6626 2320 4081 6502 2349 5581 9781 24131983 4184 6620 2406 4116 6437 2468 6076 10714 26021984 4346 6800 2550 4207 6555 2526 6733 11665 30981985 4309 6585 2634 4224 6388 2657 6360 10717 31771986 4312 6455 2746 4233 6263 2782 6472 10968 32571987 4563 6947 2835 4527 6819 2888 6052 10401 29581988 4512 6580 3002 4501 6507 3065 5991 9694 33341989 4426 6440 2972 4387 6333 3012 6100 9784 34691990 4474 6359 3109 4442 6264 3139 5987 9231 37151991 4492 6376 3136 4414 6191 3167 6483 10215 38081992 4524 6386 3170 4440 6145 3228 6481 10487 36511993 4365 6101 3096 4348 5980 3170 5677 8994 33691994 4302 5854 3184 4269 5733 3235 5855 9039 35941995 4241 5708 3168 4220 5556 3261 5829 9315 34321996 4152 5446 3210 4145 5339 3292 5416 8127 35441997 4136 5454 3160 4149 5339 3276 5359 8462 32391998 4211 5541 3249 4235 5444 3376 5484 8292 35781999 4049 5260 3160 4051 5157 3246 5431 7949 37092000 3858 4969 3049 3876 4889 3152 4895 6938 34972001 4675 6000 3695 4709 5936 3798 6015 8662 42502002 4692 5922 3800 4689 5829 3866 6245 8595 46532003 4737 6004 3809 4760 5854 3972 6164 9224 40862004 4560 5651 3761 4565 5523 3865 5634 7961 40832005 4679 5621 3989 4689 5536 4073 5812 7500 46722006 4644 5584 3943 4618 5418 4027 6067 8189 45952007 4638 5537 3967 4649 5400 4090 5879 7968 44772008 4566 5464 3909 4563 5293 4041 5950 8134 44602009 4495 5297 3907 4522 5202 4022 5636 7521 43792010 4375 5181 3769 4425 5154 3872 5098 6428 42192011 4291 5002 3757 4312 4919 3855 5272 6993 41412012 4175 4843 3676 4159 4715 3749 5427 6928 43832013 4094 4650 3678 4102 4534 3780 4972 6417 40022014 4027 4525 3657 4090 4485 3801 4660 5831 39012015 3908 4450 3495 3921 4350 3595 4749 6092 38482016 3899 4383 3530 3925 4280 3657 4571 5845 36762017 3805 4233 3488 3833 4156 3600 4439 5572 3687

Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 9: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention

Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Year of Death1975-2017 5087 7259 3493 5105 7197 3566 5738 9182 33901975-1979 4541 8014 2010 4485 7897 2021 5341 9819 19781980 4941 8471 2413 4875 8327 2422 5916 10667 24571981 4999 8516 2495 4928 8352 2510 6057 10971 25101982 5143 8679 2647 5078 8518 2672 6227 11255 26301983 5240 8704 2810 5170 8540 2828 6368 11276 28731984 5336 8822 2894 5264 8624 2927 6507 11798 27981985 5432 8854 3041 5368 8669 3081 6576 11750 29641986 5504 8895 3141 5436 8703 3176 6695 11918 31001987 5624 9005 3272 5556 8809 3304 6865 12177 32481988 5697 8987 3414 5635 8786 3457 6918 12215 33541989 5790 8977 3577 5721 8757 3627 7104 12472 34871990 5885 9056 3685 5818 8840 3731 7206 12517 36481991 5899 8988 3761 5838 8776 3812 7164 12358 37161992 5890 8801 3870 5834 8598 3921 7135 12106 38551993 5913 8760 3928 5866 8552 3997 7112 12198 37721994 5854 8569 3962 5815 8378 4030 7015 11863 38611995 5838 8437 4026 5808 8262 4097 6928 11608 38841996 5791 8282 4041 5769 8115 4122 6830 11318 39081997 5751 8133 4082 5731 7983 4152 6789 11021 40531998 5708 7989 4098 5693 7847 4169 6686 10740 40671999 5542 7697 4015 5531 7567 4086 6500 10361 40002000 5585 7648 4112 5599 7541 4208 6377 10087 39642001 5532 7532 4101 5555 7434 4205 6254 9932 38802002 5500 7367 4160 5531 7289 4264 6205 9559 40212003 5419 7203 4129 5452 7132 4230 6092 9296 40252004 5337 7043 4096 5371 6974 4199 5979 9041 39952005 5285 6949 4071 5332 6909 4170 5852 8696 40122006 5173 6739 4026 5227 6705 4136 5673 8389 39062007 5071 6517 4010 5128 6476 4130 5538 8219 38132008 4959 6373 3913 5028 6351 4040 5313 7820 36882009 4841 6154 3863 4918 6141 3997 5156 7549 35902010 4742 6006 3794 4811 5993 3917 5115 7352 36272011 4602 5789 3702 4673 5786 3821 4933 7004 35452012 4496 5624 3644 4567 5614 3766 4836 6890 34752013 4347 5399 3549 4416 5394 3666 4699 6605 34142014 4224 5200 3476 4303 5209 3602 4476 6256 32822015 4068 4983 3360 4154 4995 3497 4225 5910 30782016 3851 4697 3195 3931 4711 3321 4025 5541 29832017 3669 4449 3064 3754 4468 3195 3794 5224 2818

Table 159Cancer of the Lung and Bronchus (Invasive)

Age-adjusted US Deatha Rates by Year Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 10: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted

c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER IncidenceAge at DiagnosisAge-Adjusted Rates 2013-2017All ages 542 617 486 560 622 515 548 712 438Under 65 161 169 154 162 165 160 197 232 16765 and over 3173 3717 2779 3313 3782 2972 2977 4027 2311

All ages (WHO world std)c 379 426 344 391 427 364 397 509 319

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 01 - - 01 - - - - -5-9 - - - - - - - - -10-14 01 - 01 01 - - - - -15-19 01 01 01 01 01 02 - - -20-24 03 03 03 03 03 03 04 - -25-29 06 06 06 06 06 06 05 06 -30-34 12 11 12 11 10 12 15 17 1335-39 26 25 27 24 22 26 31 37 2640-44 63 59 67 62 57 67 64 71 5845-49 165 157 174 167 154 180 184 188 18050-54 426 419 432 429 409 449 520 568 47855-59 846 889 805 851 870 834 1088 1269 93360-64 1346 1505 1202 1364 1478 1256 1638 2097 126765-69 2155 2423 1918 2227 2429 2044 2308 3017 176970-74 3188 3553 2882 3344 3603 3122 3103 4177 234475-79 3905 4511 3432 4108 4631 3690 3594 4765 283980-84 4065 4894 3487 4256 5017 3712 3427 4719 270385+ 3088 4174 2520 3177 4243 2614 2604 3872 2071

US MortalityAge at DeathAge-Adjusted Rates 2013-2017All ages 402 493 332 410 494 345 423 588 311Under 65 110 127 95 111 125 98 134 173 10165 and over 2422 3026 1976 2480 3048 2056 2421 3462 1758

All ages (WHO world std)c 236 284 196 240 284 203 260 356 189

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 00 00 00 00 - - - - -20-24 01 01 01 01 01 00 01 - -25-29 02 02 01 02 02 01 02 02 -30-34 04 05 04 04 04 03 07 10 0435-39 12 13 11 12 12 11 17 23 1240-44 37 38 36 38 38 38 39 48 3145-49 108 113 103 112 114 109 111 132 9350-54 295 321 270 298 317 279 354 422 29355-59 600 693 511 601 679 525 759 967 58160-64 938 1141 751 944 1124 776 1150 1578 80265-69 1464 1770 1191 1488 1755 1243 1673 2360 114070-74 2227 2683 1836 2283 2695 1922 2346 3311 164975-79 2880 3511 2375 2962 3547 2485 2832 4005 206180-84 3328 4192 2713 3419 4251 2813 3065 4373 232485+ 3099 4317 2456 3159 4372 2509 2775 4211 2170

Table 1510Cancer of the Lung and Bronchus (Invasive)

SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 11: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046

8050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576

c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 60 64 56 66 68 64 48 56 42Under 65 21 21 21 24 23 24 18 21 1765 and over 326 361 300 356 382 338 251 303 216

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 - - - - - - - - -15-19 - - - - - - - - -20-24 - - - - - - - - -25-29 - - - - - - - - -30-34 01 01 - 01 - - - - -35-39 02 02 01 02 02 01 - - -40-44 05 05 05 06 06 06 05 - -45-49 20 20 20 23 22 24 15 17 1450-54 56 53 58 64 59 69 44 50 3955-59 121 120 122 135 130 140 104 107 10260-64 185 192 179 203 204 203 168 193 14865-69 279 297 263 307 314 300 233 290 18970-74 375 388 364 412 409 414 285 347 24275-79 409 451 377 449 483 421 319 364 29080-84 340 400 299 368 421 331 221 242 21085+ 166 249 122 174 256 131 134 208 102

Non-Small Cell Cancer Lung and Bronchusb Age at DiagnosisAge-Adjusted Rates 2013-2017All ages 412 467 370 421 467 388 432 559 345Under 65 129 134 124 127 128 126 163 191 14065 and over 2368 2775 2070 2452 2804 2194 2290 3109 1765

Age-Specific Rates 2013-2017lt1 - - - - - - - - -1-4 - - - - - - - - -5-9 - - - - - - - - -10-14 00 - - - - - - - -15-19 01 01 01 01 01 01 - - -20-24 03 02 03 02 02 03 04 - -25-29 05 05 06 05 05 06 04 - -30-34 10 09 11 10 08 11 12 13 1235-39 23 21 25 21 19 24 26 30 2440-44 54 50 58 52 47 58 53 59 4845-49 137 127 146 135 122 148 157 162 15450-54 343 334 352 338 319 357 439 472 41155-59 668 699 639 660 671 649 905 1048 78260-64 1057 1178 947 1055 1142 973 1330 1692 103765-69 1699 1901 1520 1735 1885 1598 1881 2451 144870-74 2498 2783 2260 2600 2803 2425 2487 3337 188775-79 3016 3500 2638 3144 3562 2810 2864 3858 222380-84 2959 3593 2517 3078 3667 2658 2542 3569 196785+ 1770 2490 1393 1809 2528 1429 1503 2262 1183

Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)

SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 12: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

d Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1960-1963a - - - 8 7 11 5 5 61970-1973a - - - 10 9 14 7 6 101975-1977b 122 110 153 122 110 155 112 105 1381978-1980b 128 113 163 129 115 162 117 97 1781981-1983b 131 115 164 133 117 166 114 102 1491984-1986b 128 112 160 130 112 163 111 103 1281987-1989b 130 119 149 132 120 153 109 108 1111990-1992b 136 121 159 140 125 162 105 93 1271993-1995b 143 125 169 145 126 171 128 112 1571996-1998b 146 129 168 148 131 170 123 106 1511999-2001b 153 131 179 155 133 181 127 108 1542002-2004b 161 142 184 165 144 189 133 127 1412005-2009b 184 158 212 188 162 216 155 133 1802010-2016b 218f 183f 255f 219f 185f 255f 204f 169f 241f

5-Year Period Survival (Percent)cd

2016 217 181 257 218 181 257 195 162 232

Stage Distribution () 2010-2016ce

All StagesNumber of cases 262454 137025 125429 211444 109049 102395 30626 16646 13980Percent 100 100 100 100 100 100 100 100 100Localized 17 15 19 18 16 20 14 12 16Regional 22 22 22 22 22 22 22 21 23Distant 57 59 54 56 58 54 61 63 58UnstagedUnknown 4 4 4 4 4 5 3 3 3

5-Year Relative Survival (Percent) 2010-2016c

Age at DiagnosisAges lt45 366 312 417 381 328 429 288 244 341Ages 45-54 235 186 287 236 186 288 215 168 267Ages 55-64 220 182 268 219 182 266 198 162 250Ages 65-74 222 186 264 224 187 264 188 156 228Ages 75+ 158 131 183 160 133 185 123 92 149Ages lt65 231 188 282 231 188 280 207 167 260Ages 65+ 191 161 222 193 162 223 162 133 192

StageeAll Stages 205 171 242 206 172 242 184 151 223Localized 590 530 641 591 532 640 548 468 618Regional 317 281 357 314 279 351 306 270 346Distant 58 47 71 55 43 67 60 51 71UnstagedUnknown 83 77 90 75 67 83 91 84 97

Table 1512Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 13: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)

Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey

Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 36 31 48 37 31 49 37 38 361978-1980a 42 32 65 43 33 64 31 24 501981-1983a 45 35 62 46 36 61 53 41 821984-1986a 45 35 62 47 36 64 35 22 561987-1989a 50 39 66 51 38 68 40 33 511990-1992a 54 45 64 54 45 65 42 39 441993-1995a 64 51 78 62 50 76 67 40 1041996-1998a 58 53 65 60 55 66 36 26 451999-2001a 57 48 67 56 44 69 52 60 422002-2004a 65 47 82 65 44 85 53 53 512005-2009a 68 52 85 67 51 84 67 45 892010-2016a 70e 57e 82e 70e 57e 82e 75e 71e 78

5-Year Period Survival (Percent)bc

2016 67 50 84 67 49 84 77 70 85

Stage Distribution () 2010-2016bd

All StagesNumber of cases 33251 16684 16567 28703 14145 14558 3033 1549 1484Percent 100 100 100 100 100 100 100 100 100Localized 4 4 4 4 3 4 4 4 4Regional 20 18 22 20 18 22 19 17 21Distant 75 77 72 75 77 72 75 77 74UnstagedUnknown 2 2 2 2 2 2 2 2 1

5-Year Relative Survival (Percent) 2010-2016b

Age at DiagnosisAges lt45 133 96 172 140 109 173 106 - -Ages 45-54 97 70 121 94 64 120 121 116 128Ages 55-64 78 57 100 78 56 100 80 59 101Ages 65-74 62 55 70 62 53 71 71 79 62Ages 75+ 37 28 45 37 27 45 35 21 45Ages lt65 84 61 107 83 59 107 92 75 109Ages 65+ 52 45 60 52 43 60 58 61 55

StagedAll Stages 65 51 79 65 50 79 75 68 82Localized 272 255 283 272 254 284 349f 374f 321f

Regional 164 148 177 165 147 180 175 161 187Distant 29 20 38 28 19 37 38 33 42UnstagedUnknown 81 57 102 80 42 110 34 66f -

Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 14: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576

a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2017 Expected survival rates are derived from the US Annual Life Tables

b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2017

c Period survival provides a 2016 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)

d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2010-2016 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis1975-1977a 164 148 211 167 150 215 134 124 1771978-1980a 167 148 214 170 152 215 142 116 2281981-1983a 171 150 217 175 154 221 139 122 1921984-1986a 166 144 210 170 147 215 131 119 1641987-1989a 168 152 198 173 155 205 132 129 1391990-1992a 177 155 211 183 162 217 128 111 1621993-1995a 187 161 225 193 165 233 151 133 1851996-1998a 194 167 229 199 171 235 153 127 1951999-2001a 200 169 241 207 175 247 148 120 1892002-2004a 196 170 228 204 177 237 150 139 1662005-2009a 222 189 260 231 197 268 174 148 2062010-2016a 265e 221e 312e 270e 225e 318e 234e 190e 281e

5-Year Period Survival (Percent)bc2016 263 218 312 268 221 317 224 184 271

Stage Distribution () 2010-2016bdAll StagesNumber of cases 199070 104884 94186 157707 82267 75440 24448 13379 11069Percent 100 100 100 100 100 100 100 100 100Localized 20 17 23 21 18 24 16 14 18Regional 24 24 23 24 25 24 24 23 24Distant 54 57 52 53 55 51 59 62 56UnstagedUnknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent) 2010-2016bAge at DiagnosisAges lt45 387 333 437 406 350 456 301 261 348Ages 45-54 264 208 323 270 212 330 230 175 287Ages 55-64 257 212 314 260 216 316 221 182 278Ages 65-74 267 222 317 272 227 322 216 175 267Ages 75+ 208 170 245 213 174 249 158 117 197Ages lt65 265 216 324 270 220 328 227 184 284Ages 65+ 240 199 283 244 203 287 194 154 238

StagedAll Stages 249 206 297 253 210 301 211 170 260Localized 631 567 684 632 570 684 581 491 659Regional 354 309 406 352 308 401 333 291 380Distant 69 56 86 66 52 82 66 56 80UnstagedUnknown 148 142 155 137 129 146 115 94 135

Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)

5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 15: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 353 371 384 393 405 398 401 397 416 407 400 405 420 420 433 438 445 450 456 447 469 458 479 480 502 5182-year 211 219 226 237 249 246 246 252 259 258 255 265 266 277 284 295 301 309 314 312 329 318 336 350 3723-year 163 169 171 183 191 193 193 199 198 202 198 207 208 223 226 235 240 248 253 250 265 256 274 2894-year 140 145 146 155 165 163 166 170 170 175 168 175 179 189 195 200 206 214 217 216 230 222 2425-year 125 129 130 138 145 146 147 146 152 157 150 156 160 168 174 176 184 189 196 194 205 1996-year 114 117 119 127 132 132 133 133 137 142 135 141 145 154 157 162 168 173 179 178 1877-year 107 108 109 116 123 121 122 122 127 130 124 129 133 141 146 151 154 160 166 1628-year 100 100 101 107 115 112 113 112 118 120 115 119 121 132 135 141 142 146 1539-year 94 92 94 99 107 103 104 105 111 112 106 111 111 125 125 127 133 13610-year 88 86 88 92 100 95 98 100 105 104 101 104 103 116 116 117 12411-year 83 82 82 86 94 88 92 94 97 98 94 95 98 108 109 11212-year 78 77 77 80 89 83 85 89 91 91 88 89 93 101 10313-year 74 72 72 75 82 79 80 81 86 86 82 83 87 9414-year 71 68 68 71 77 76 75 76 80 81 77 79 7915-year 66 64 64 67 73 70 71 71 76 77 72 7616-year 63 60 61 63 69 67 66 68 72 75 6917-year 60 56 57 59 64 63 62 63 68 7118-year 57 53 53 55 59 60 57 61 6419-year 54 50 50 52 55 56 54 5820-year 52 46 47 49 52 53 5021-year 49 43 45 46 50 5022-year 47 41 42 44 4723-year 44 38 40 4124-year 42 36 3825-year 40 34 3626-year 38 32 3527-year 36 31 3328-year 35 29 3129-year 33 2730-year 32 26

Table 1515Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males and Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 16: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 334 352 364 371 382 379 378 367 384 385 367 369 395 388 397 411 410 418 425 410 426 416 427 439 469 4782-year 195 202 210 216 231 229 229 227 228 237 222 232 238 247 247 269 262 277 275 274 286 280 280 309 3333-year 148 153 156 164 173 177 177 174 167 182 172 180 182 195 195 208 209 220 219 216 225 221 221 2524-year 125 129 131 137 148 146 150 147 141 156 144 151 155 167 166 173 176 189 184 186 190 189 1945-year 111 114 116 121 132 131 133 124 125 141 127 136 141 149 148 151 157 167 165 165 168 1686-year 101 104 106 110 118 117 119 110 112 126 116 122 126 135 132 139 143 152 151 152 1537-year 94 95 97 100 112 106 108 101 103 114 105 112 116 123 122 128 128 141 137 1398-year 88 87 90 91 102 98 101 90 95 107 96 101 108 114 112 119 117 129 1269-year 82 79 84 84 96 91 92 85 88 100 89 93 99 108 104 107 109 12010-year 76 74 79 79 88 82 86 80 83 92 84 87 89 100 95 96 10011-year 72 70 73 72 83 74 80 75 77 85 78 81 84 94 88 8912-year 67 66 68 67 80 69 73 70 72 78 73 74 81 87 8313-year 63 62 63 62 73 67 68 63 68 73 65 69 76 8214-year 60 58 60 58 69 63 64 59 63 67 62 65 6915-year 56 55 56 55 64 58 61 56 59 65 55 6316-year 53 50 53 51 62 55 57 52 58 63 5317-year 51 46 49 48 58 52 53 49 54 6018-year 47 44 45 45 53 49 49 46 5119-year 45 41 42 43 46 46 45 4520-year 42 38 39 40 43 45 4021-year 41 35 36 37 41 4122-year 39 33 34 35 3823-year 37 31 32 3224-year 34 28 3025-year 33 27 2826-year 31 25 2627-year 28 25 2528-year 28 24 2329-year 27 2230-year 26 21

Table 1516Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Males

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 17: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables

1975- 1980- 1985- 1990-1979 1984 1989 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

SurvivalTime

1-year 404 413 420 427 436 423 430 435 456 436 441 447 450 457 472 469 484 486 489 488 515 504 534 523 537 5602-year 254 257 255 267 275 269 268 285 296 285 296 305 299 311 323 326 344 345 355 355 374 359 396 392 4143-year 203 205 197 211 216 214 213 230 236 227 230 240 238 254 261 266 274 278 290 287 308 295 329 3284-year 178 178 172 183 188 184 185 199 205 199 199 204 207 215 228 230 238 241 252 249 271 258 2945-year 161 160 154 164 165 165 164 174 184 177 178 179 183 190 202 204 213 212 230 225 244 2326-year 150 146 141 151 150 152 150 161 168 161 158 164 168 176 185 188 196 196 210 207 2237-year 140 136 129 139 139 141 140 149 156 150 147 150 153 163 171 177 182 179 196 1888-year 131 128 120 130 131 131 128 139 147 136 138 140 136 152 160 165 170 164 1819-year 124 119 112 121 123 120 119 131 138 128 127 131 127 143 148 150 160 15410-year 116 111 104 113 116 111 112 124 131 120 122 124 119 133 139 142 15011-year 111 106 98 106 110 107 106 119 122 113 115 113 114 123 131 13712-year 107 99 93 99 101 101 99 113 114 107 107 106 107 116 12513-year 103 93 88 94 94 96 94 105 107 102 102 99 99 10714-year 97 89 82 89 87 91 89 97 100 96 96 95 9115-year 92 84 78 84 84 87 83 91 96 92 92 9016-year 89 80 74 79 79 82 76 86 89 90 8917-year 84 77 71 74 73 78 72 81 85 8418-year 80 72 67 70 68 74 67 78 8119-year 77 66 63 65 65 69 64 7320-year 74 63 61 62 63 64 6221-year 69 59 59 59 61 6222-year 65 56 55 56 5823-year 62 53 54 5424-year 60 51 5125-year 58 48 4926-year 56 46 4827-year 54 42 4628-year 52 40 4429-year 49 3730-year 46 36

Table 1517Cancer of the Lung and Bronchus (Invasive)

SEERa Relative Survival (Percent)By Year of Diagnosis

All Races Females

Year of Diagnosis

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 18: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 627 476 Asian 0 000 000 001 553 395

10 000 001 003 633 481 Pacific 10 000 001 003 557 398

20 000 002 014 635 483 Islander 20 001 003 013 558 399

30 002 013 071 641 488 30 002 012 051 560 400

40 012 070 215 647 494 40 010 049 151 561 401

50 060 208 446 651 501 50 039 143 316 557 401

60 157 410 589 627 488 60 107 285 456 534 392

70 286 488 - 532 430 70 192 375 - 458 359

80 270 - - 327 294 80 218 - - 316 284

White 0 000 000 001 645 487 American 0 000 000 000 445 351

10 000 001 002 650 492 Indian 10 000 000 001 449 356

20 000 002 014 652 494 Alaska 20 000 001 009 451 358

30 002 013 071 657 499 Nativea 30 001 009 048 459 365

40 012 071 219 665 505 40 008 048 146 471 377

50 060 212 461 669 511 50 042 144 320 482 391

60 161 424 609 645 498 60 110 300 425 474 391

70 298 506 - 547 438 70 217 360 - 415 356

80 279 - - 334 298 80 192 - - 266 239

Black 0 000 000 001 554 430 Hispanicb 0 000 000 001 403 264

10 000 001 003 564 439 10 000 000 002 406 266

20 000 003 015 566 441 20 000 002 007 407 267

30 002 015 083 573 448 30 001 007 032 410 269

40 013 083 235 582 456 40 005 031 106 413 271

50 072 230 436 590 466 50 026 102 244 415 273

60 172 395 530 563 454 60 079 228 357 406 272

70 267 427 - 467 396 70 163 306 - 360 252

80 226 - - 283 270 80 178 - - 246 193

Table 1518

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Both Sexes 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 19: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 657 522 Asian 0 000 000 001 671 490

10 000 001 002 664 529 Pacific 10 000 001 002 676 494

20 000 002 013 666 531 Islander 20 001 002 012 677 496

30 002 013 071 675 539 30 002 012 055 680 498

40 011 071 227 685 549 40 010 054 180 683 501

50 061 223 478 695 560 50 045 172 391 684 503

60 173 447 640 680 554 60 132 359 573 664 495

70 319 544 - 591 497 70 248 482 - 581 458

80 317 - - 383 353 80 290 - - 413 370

White 0 000 000 001 658 527 American 0 000 000 000 433 363

10 000 001 002 665 533 Indian 10 000 000 001 438 368

20 000 002 012 667 535 Alaska 20 000 001 008 440 371

30 002 012 069 675 543 Nativea 30 001 008 043 450 381

40 011 069 224 686 553 40 007 044 135 465 396

50 060 220 480 696 563 50 038 134 312 482 416

60 172 450 646 683 557 60 105 300 443 486 429

70 324 551 - 594 499 70 228 396 - 447 405

80 322 - - 383 354 80 238 - - 309 268

Black 0 000 000 001 634 512 Hispanicb 0 000 000 000 449 327

10 000 001 003 646 523 10 000 000 001 453 330

20 001 003 017 650 527 20 000 001 006 454 332

30 003 016 094 662 538 30 001 006 031 459 335

40 014 093 280 677 552 40 005 030 112 464 340

50 083 279 525 693 570 50 026 110 274 471 345

60 217 490 642 677 568 60 089 263 418 471 348

70 344 535 - 579 506 70 196 372 - 432 330

80 295 - - 363 353 80 232 - - 311 258

Table 1519

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Males 2015-2017 By RaceEthnicity

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 20: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Devcan 678 April 2020 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta

San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US

a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties

b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry

- Statistic could not be calculatedA percent of 000 represents a value that is below 0005

Risk of Being Risk of Being

Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying

Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer

All Races 0 000 000 001 604 434 Asian 0 000 000 001 457 319

10 000 001 003 609 438 Pacific 10 000 001 003 460 321

20 001 003 015 610 439 Islander 20 001 003 013 461 322

30 002 014 071 613 442 30 003 013 047 461 322

40 012 069 203 616 446 40 010 044 126 460 323

50 058 194 418 615 448 50 035 118 252 454 321

60 143 376 544 583 431 60 085 223 361 429 312

70 258 443 - 485 376 70 145 291 - 363 284

80 236 - - 290 253 80 167 - - 250 226

White 0 000 000 001 636 451 American 0 000 000 000 460 341

10 000 001 003 641 455 Indian 10 000 000 001 464 345

20 001 003 015 642 456 Alaska 20 000 001 009 466 347

30 002 015 074 644 459 Nativea 30 001 009 052 471 351

40 013 072 214 648 463 40 009 053 156 479 359

50 061 205 444 647 465 50 045 152 329 485 368

60 151 401 577 613 447 60 113 300 412 466 357

70 276 470 - 510 388 70 207 331 - 391 315

80 248 - - 300 258 80 160 - - 237 218

Black 0 000 000 001 489 361 Hispanicb 0 000 000 001 368 212

10 000 000 002 497 368 10 000 001 002 371 214

20 000 002 014 498 369 20 000 002 008 371 214

30 002 014 074 501 371 30 001 007 033 372 215

40 012 073 196 505 376 40 006 032 100 373 216

50 063 190 362 508 381 50 026 096 220 372 216

60 135 319 442 476 366 60 071 199 309 356 211

70 211 352 - 390 319 70 138 256 - 307 195

80 187 - - 238 223 80 142 - - 204 151

Table 1520

Cancer of the Lung and Bronchus (Invasive)

Risk of Being Diagnosed With Cancer in 10 20 and 30 Years

Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and

Lifetime Risk of Dying from Cancer Given Alive at Current Age

Females 2015-2017 By RaceEthnicity

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 21: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 48 April 2020 National Cancer Institute

- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval

a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts

c The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2017

d The 2008-2017 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2017

e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry

f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties

g US Mortality Files National Center for Health Statistics CDCh The 2008-2017 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2017 The APC is significantly different from zero (plt05)

SEER Incidence SEER 21 Areasb SEER 21 Areasb SEER 9 Areasb

Rate 2013-2017 Trend 2008-2017c Trend 2008-2017d

Rate per 100000 persons AAPC () AAPC ()

Total Males Females Total Males Females Total Males Females RaceEthnicity

All Races 542 617 486 -21 -29 -15 -22 -29 -16

White 560 622 515 -21 -29 -15 -22 -29 -16White Hispanice 296 358 254 -25 -36 -14 - - -White Non-Hispanice 602 662 558 -19 -27 -13 - - -

Black 548 712 438 -26 -29 -19 -28 -30 -21

AsianPacific Islander 362 462 286 -09 -16 01 - - -

Amer IndAlaska Natf 381 435 343 -16 -21 -10 - - -

Hispanice 290 351 248 -22 -32 -11 - - -

US Mortalityg Rate 2013-2017 Trend 2008-2017h

Rate per 100000 persons AAPC ()

Total Males Females Total Males FemalesRaceEthnicity

All Races 402 493 332 -33 -39 -27

White 410 494 345 -32 -38 -26White Hispanice 185 255 134 -32 -40 -21White Non-Hispanice 434 518 368 -31 -36 -25

Black 423 588 311 -37 -44 -31

AsianPacific Islander 222 293 169 -22 -29 -18

Amer IndAlaska NatTotal US 263 320 219 -30 -41 -29PRCDA Counties 334 401 284 -31 -36 -21Non-PRCDA Counties 183 232 144 -30 -33 -29

Hispanice 176 242 127 -33 -40 -22

Table 1521Lung and Bronchus (Invasive)

SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa

By RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 22: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta

The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Incidence Ratesa 2013-2017

California 4146 4638 3778 4217 4583 3950 5091 6037 4428Greater Bay Area 3973 4447 3622 3966 4173 3832 5462 6557 4683San Francisco-Oakland 4079 4533 3748 4003 4124 3939 5739 6903 4935San Jose-Monterey 3766 4282 3373 3901 4257 3644 3685 4554 2893

Los Angeles 3631 4315 3129 3532 4094 3117 5102 6141 4421Greater California 4435 4843 4128 4543 4877 4297 4906 5701 4308

Connecticut 5957 6497 5582 6058 6518 5745 5400 7064 4370Detroit 6894 7800 6255 6920 7622 6440 7234 9078 6004Georgia 6279 7904 5058 6644 8041 5560 5601 8049 4002Atlanta 5075 6010 4424 5206 5805 4789 5185 6936 4110Rural Georgia 6484 8910 4601 6382 8146 4867 6665 11206 3852Greater Georgia 6843 8719 5400 7166 8815 5867 5904 8740 3965

Hawaii 4571 5725 3625 4498 4910 4066 4834 4419 5412Idaho 4949 5425 4573 4946 5422 4573 - - -Iowa 6327 7473 5455 6322 7444 5472 7821 9853 6197Kentucky 9101 10895 7747 9214 11021 7841 8454 10184 7309Louisiana 6621 8262 5355 6600 7791 5684 6844 9913 4673Massachusetts 6121 6499 5890 6283 6589 6116 4375 5214 3815New Jersey 5532 6075 5170 5819 6279 5523 5182 6286 4518New Mexico 3852 4390 3434 4022 4538 3619 4706 6051 3568New York 5867 6617 5343 6227 6807 5837 4649 5957 3820Seattle-Puget Sound 5515 6032 5132 5642 6080 5316 5771 6855 4917Utah 2599 3021 2252 2590 3011 2243 4293 4110 4543

SEER 9 Areasb 5189 5877 4676 5280 5814 4886 5960 7548 4900SEER 13 Areasb 4777 5465 4265 4856 5394 4459 5730 7202 4743SEER 18 Areasb 5263 6057 4663 5413 6074 4915 5843 7621 4623SEER 21 Areasb 5417 6172 4859 5604 6222 5153 5480 7119 4378

Table 1522Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Incidence Ratesa

By Registry Race and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 23: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)

b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts

- Statistic not shown Rate based on less than 16 cases for the time interval

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

SEER Death Ratesa 2013-2017

California 2955 3499 2539 3033 3486 2685 3774 4731 3097Greater Bay Area 2681 3143 2330 2716 3005 2500 3840 4792 3155San Francisco-Oakland 2763 3220 2420 2740 2989 2560 4075 5151 3310San Jose-Monterey 2520 2995 2153 2673 3033 2393 2342 2688 2056

Los Angeles 2635 3292 2151 2570 3126 2153 3931 4918 3284Greater California 3193 3711 2791 3294 3751 2939 3591 4537 2864

Connecticut 3468 3967 3104 3554 3986 3239 3157 4508 2317Detroit 4537 5360 3946 4505 5172 4032 5010 6623 3939Georgia 4264 5673 3213 4501 5762 3522 3842 5819 2570Atlanta 3313 4203 2691 3319 3986 2834 3500 5011 2589Rural Georgia 4750 6645 3320 4653 6165 3359 4918 7869 3194Greater Georgia 4695 6298 3472 4914 6366 3776 4079 6332 2557

Hawaii 3049 3897 2353 3233 3470 2991 3257 - -Idaho 3357 3905 2904 3381 3939 2919 - - -Iowa 4320 5404 3487 4316 5401 3485 5735 6857 4727Kentucky 6364 8077 5060 6449 8169 5129 5772 7556 4609Louisiana 4965 6452 3815 4883 6004 4001 5361 8086 3468Massachusetts 3869 4486 3433 4002 4586 3593 2686 3528 2091New Jersey 3524 4104 3114 3691 4228 3312 3608 4735 2901New Mexico 2848 3342 2460 2993 3476 2610 3415 4634 2327New York 3535 4254 3015 3787 4432 3317 2893 3901 2260Seattle-Puget Sound 3599 4170 3150 3711 4207 3318 3689 4762 2722Utah 1855 2231 1540 1850 2229 1532 3417 - -

SEER 9 Areasb 3417 4069 2921 3482 4031 3062 4048 5433 3120SEER 13 Areasb 3208 3857 2716 3266 3811 2848 4000 5288 3137SEER 18 Areasb 3610 4384 3018 3717 4399 3190 4165 5748 3084SEER 21 Areasb 3609 4360 3041 3742 4408 3235 3781 5207 2827

Total US 4023 4933 3323 4105 4944 3451 4230 5883 3107

Table 1523Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted SEER Death Ratesa

By Registry Race and Sex

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 24: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4023 005

High Five StatesKentucky 6364 050 01(0101) 5818c

Arkansas 5546 055 02(0204) 3785c

West Virginia 5490 066 03(0205) 3645c

Mississippi 5465 057 04(0205) 3583c

Tennessee 5357 037 05(0306) 3313c

Low Five StatesHawaii 3049 059 47(4649) -2421c

California 2955 012 48(4749) -2656c

New Mexico 2848 048 49(4850) -2921c

Colorado 2791 032 50(4950) -3063c

Utah 1855 040 51(5151) -5390c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 5036 041 09(0611) 2517c Montana 3727 076 36(3041) -738c

Alaska 3961 123 30(1938) -156 Nebraska 3978 061 29(2534) -113Arizona 3288 028 45(4346) -1827c Nevada 4192 053 25(1827) 418Arkansas 5546 055 02(0204) 3785c New Hampshire 4249 072 23(1727) 561c

California 2955 012 48(4749) -2656c New Jersey 3524 026 41(3843) -1241c

Colorado 2791 032 50(4950) -3063c New Mexico 2848 048 49(4850) -2921c

Connecticut 3468 040 42(3944) -1380c New York 3535 017 40(3843) -1215c

Delaware 4502 087 16(1322) 1190c North Carolina 4607 028 13(1316) 1449c

DC 3381 104 43(3747) -1596c North Dakota 3668 094 38(3043) -884c

Florida 3914 016 31(2834) -273 Ohio 4845 026 12(1012) 2042c

Georgia 4264 029 22(1825) 598c Oklahoma 5202 048 06(0508) 2929c

Hawaii 3049 059 47(4649) -2421c Oregon 3858 040 34(2936) -411Idaho 3357 061 44(4046) -1657c Pennsylvania 4232 023 24(1926) 517c

Illinois 4300 024 19(1724) 686c Rhode Island 4519 084 15(1321) 1231c

Indiana 5085 037 07(0610) 2638c South Carolina 4483 039 17(1318) 1142c

Iowa 4320 048 18(1725) 736c South Dakota 4069 090 26(1934) 113Kansas 4290 051 20(1726) 661c Tennessee 5357 037 05(0306) 3313c

Kentucky 6364 050 01(0101) 5818c Texas 3582 017 39(3741) -1096c

Louisiana 4965 044 10(0712) 2341c Utah 1855 040 51(5151) -5390c

Maine 4879 072 11(0812) 2126c Vermont 4280 103 21(1429) 638c

Maryland 3881 034 32(2935) -355 Virginia 4040 030 27(2530) 040Massachusetts 3869 031 33(2935) -384 Washington 3729 031 35(3438) -733c

Michigan 4552 028 14(1317) 1314c West Virginia 5490 066 03(0205) 3645c

Minnesota 3692 034 37(3439) -823c Wisconsin 4014 034 28(2631) -023Mississippi 5465 057 04(0205) 3583c Wyoming 3220 100 46(4148) -1996c

Missouri 5081 037 08(0610) 2629c

Table 1524Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males and Females

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 25: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 4933 008

High Five StatesKentucky 8077 085 01(0101) 6374c

Mississippi 7551 103 02(0203) 5307c

Arkansas 7185 095 03(0205) 4566c

Tennessee 6998 065 04(0306) 4186c

West Virginia 6940 111 05(0306) 4068c

Low Five StatesWyoming 3643 158 47(4049) -2616c

California 3499 020 48(4749) -2907c

New Mexico 3342 078 49(4750) -3226c

Colorado 3094 052 50(4950) -3727c

Utah 2231 064 51(5151) -5478c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 6839 074 06(0406) 3864c Montana 3942 115 43(3847) -2008c

Alaska 4579 198 32(2242) -717c Nebraska 4838 101 26(2232) -192Arizona 3821 045 46(4247) -2254c Nevada 4596 081 31(2636) -683c

Arkansas 7185 095 03(0205) 4566c New Hampshire 4831 115 27(2234) -207California 3499 020 48(4749) -2907c New Jersey 4104 043 40(3943) -1679c

Colorado 3094 052 50(4950) -3727c New Mexico 3342 078 49(4750) -3226c

Connecticut 3967 065 42(4046) -1959c New York 4254 029 39(3540) -1375c

Delaware 5509 146 16(1323) 1167c North Carolina 6003 050 12(1114) 2170c

DC 4025 176 41(3247) -1841c North Dakota 4556 156 33(2440) -765c

Florida 4747 027 29(2531) -377 Ohio 6042 044 11(1014) 2248c

Georgia 5673 052 15(1417) 1500c Oklahoma 6493 081 07(0710) 3163c

Hawaii 3897 099 45(4047) -2099c Oregon 4345 063 36(3340) -1192c

Idaho 3905 097 44(4047) -2084c Pennsylvania 5250 038 20(1823) 644c

Illinois 5237 041 21(1824) 615c Rhode Island 5319 139 19(1525) 782c

Indiana 6406 063 09(0710) 2987c South Carolina 5886 068 14(1115) 1932c

Iowa 5404 080 18(1522) 955c South Dakota 4995 148 24(1732) 125Kansas 5191 084 22(1725) 523c Tennessee 6998 065 04(0306) 4186c

Kentucky 8077 085 01(0101) 6374c Texas 4532 029 34(3035) -812c

Louisiana 6452 077 08(0710) 3080c Utah 2231 064 51(5151) -5478c

Maine 5920 119 13(1016) 2002c Vermont 4965 166 25(1734) 065Maryland 4629 058 30(2735) -617c Virginia 5050 051 23(2126) 238Massachusetts 4486 051 35(3037) -907c Washington 4301 050 37(3440) -1280c

Michigan 5432 045 17(1620) 1012c West Virginia 6940 111 05(0306) 4068c

Minnesota 4262 055 38(3541) -1361c Wisconsin 4805 056 28(2431) -260Mississippi 7551 103 02(0203) 5307c Wyoming 3643 158 47(4049) -2616c

Missouri 6260 062 10(0811) 2689c

Table 1525Cancer of the Lung and Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Males

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 26: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)

b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval

State Rate SE Rank(CI)d PD TOTAL US 3323 006

High Five StatesKentucky 5060 060 01(0101) 5227c

West Virginia 4364 081 02(0206) 3132c

Arkansas 4253 066 03(0208) 2796c

Oklahoma 4192 059 04(0209) 2612c

Missouri 4179 046 05(0209) 2575c

Low Five StatesColorado 2564 042 47(4649) -2284c

California 2539 015 48(4649) -2359c

New Mexico 2460 061 49(4750) -2599c

Hawaii 2353 071 50(4750) -2920c

Utah 1540 049 51(5151) -5365c

State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD

Alabama 3675 047 18(1423) 1059c Montana 3584 102 21(1233) 785Alaska 3420 157 27(1242) 290 Nebraska 3324 076 32(2239) 003Arizona 2842 036 46(4146) -1450c Nevada 3837 069 13(0819) 1546c

Arkansas 4253 066 03(0208) 2796c New Hampshire 3818 093 14(0722) 1490c

California 2539 015 48(4649) -2359c New Jersey 3114 032 38(3642) -629Colorado 2564 042 47(4649) -2284c New Mexico 2460 061 49(4750) -2599c

Connecticut 3104 050 39(3443) -660 New York 3015 022 40(3944) -928Delaware 3728 106 17(0828) 1218c North Carolina 3564 033 22(1726) 723DC 2897 128 44(3448) -1283c North Dakota 2973 117 41(3246) -1055c

Florida 3227 020 36(3138) -290 Ohio 3944 032 10(0814) 1867c

Georgia 3213 034 37(3139) -331 Oklahoma 4192 059 04(0209) 2612c

Hawaii 2353 071 50(4750) -2920c Oregon 3482 052 24(1831) 477Idaho 2904 078 43(3846) -1262c Pennsylvania 3481 028 25(2029) 475Illinois 3607 030 19(1624) 852 Rhode Island 3985 105 09(0318) 1991c

Indiana 4081 045 07(0410) 2279c South Carolina 3404 046 29(2234) 242Iowa 3487 058 23(1832) 493 South Dakota 3394 113 30(1640) 212Kansas 3594 064 20(1529) 815 Tennessee 4107 044 06(0310) 2359c

Kentucky 5060 060 01(0101) 5227c Texas 2846 020 45(4146) -1437c

Louisiana 3815 052 15(0918) 1479c Utah 1540 049 51(5151) -5365c

Maine 4074 090 08(0215) 2260c Vermont 3735 131 16(0631) 1237c

Maryland 3336 042 31(2537) 037 Virginia 3261 036 35(2938) -186Massachusetts 3433 039 26(2132) 330 Washington 3277 040 33(2838) -141Michigan 3883 034 12(0816) 1684c West Virginia 4364 081 02(0206) 3132c

Minnesota 3263 044 34(2838) -182 Wisconsin 3415 043 28(2233) 275Mississippi 3912 064 11(0717) 1770c Wyoming 2917 132 42(3248) -1223c

Missouri 4179 046 05(0209) 2575c

Table 1526Cancer of the Lung And Bronchus (Invasive)

Age-Adjusted Cancer Deatha Rates By State All Races 2013-2017

Females

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 27: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112017 US population estimates based on the average of 2016 and 2017 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years

b Maximum limited-duration prevalence is 25 years for 1992-2017 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et al 1997

Merrill et al 2000)e Complete prevalence is obtained by summing lt=25 and gt 25- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available

Years Since Diagnosis 0 to 5 gt 5 to 10 gt 10 to 15 gt 15 to 20 gt 20 to 25 lt=25b gt 25d Completee

Race Sex All Races Both Sexes 309999 109572 54256 28332 14971 517130 41120 558250

Males 141510 45588 21736 11364 6138 226337 21765 248102Females 168488 63984 32519 16968 8833 290793 19355 310148

White Both Sexes 258339 93440 46822 24613 12939 436153 24670 460823Males 116834 38583 18374 9649 5184 188624 11651 200275Females 141505 54857 28448 14964 7755 247530 13019 260548

Black Both Sexes 36049 11452 5411 2605 1499 57017 2802 59819Males 17097 4951 2443 1198 686 26375 1431 27806Females 18952 6501 2968 1407 813 30642 1371 32013

Asian Both Sexes 12447 3592 1679 846 379 18944 + +Pacific Males 6106 1598 791 397 192 9084 + +Islander Females 6341 1994 889 450 187 9860 + +

Hispanic Both Sexes 14069 4565 2209 1153 581 22577 + +Males 6217 1853 926 451 244 9692 + +Females 7852 2712 1282 702 337 12885 + +

Age Specific (Crude) Age-Adjustedc Age at Prevalence All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages

Race Sex All Races Both Sexes 01596 00004 00004 00020 00066 00250 01250 03820 08972 09877 01332

Males 01418 00003 00005 00017 00059 00216 01058 03676 08840 10532 01308Females 01768 00004 00003 00022 00072 00285 01434 03950 09082 09470 01361

White Both Sexes 01724 00003 00005 00021 00069 00250 01196 03744 09105 10089 01336Males 01504 00002 00006 00016 00061 00211 00990 03515 08760 10544 01284Females 01939 00004 00004 00026 00077 00291 01398 03956 09400 09801 01389

Black Both Sexes 01252 00007 00003 00017 00051 00249 01695 04765 09086 08480 01408Males 01207 00008 00005 00023 00055 00248 01530 05204 10559 10662 01584Females 01294 00005 - 00012 00046 00249 01839 04414 08056 07391 01300

Asian Both Sexes 00908 - - 00012 00056 00238 00995 02915 06085 07913 00997Pacific Males 00909 - - 00013 00038 00200 00972 03137 06950 09516 01109Islander Females 00908 - - 00010 00072 00271 01016 02737 05393 06868 00917

Hispanic Both Sexes 00388 00001 00002 00015 00042 00131 00543 01617 04417 05334 00653Males 00330 00001 00002 00011 00031 00109 00454 01456 04429 06119 00655Females 00448 00002 00002 00019 00054 00154 00631 01760 04408 04847 00661

Table 1527Cancer of the Lung And Bronchus (Invasive)

Estimated United States Cancer Prevalence Countsa on January 1 2017By RaceEthnicity Sex and Years Since Diagnosis

Estimated prevalence percenta on January 1 2017 of the SEER population diagnosed in the previous 25 yearsBy Age at Prevalence RaceEthnicity and Sex

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 28: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 478 319082 998 261850 998 34890 998 19767 998 1089 998 19717 995

Small cell (80028041-8045) 59 39968 125 34951 133 3409 97 1335 67 153 140 2029 102

Non-small cell 405 269735 843 219330 836 30289 866 17918 904 886 812 17018 859

Squamous and 109 72205 226 60448 230 8247 236 2876 145 326 299 3818 193

transitional celld

Adenocarcinomae 241 161224 504 128729 490 17900 512 13318 672 450 412 10664 538

Large cellf 06 4150 13 3361 13 583 17 183 09 - - 226 11

Non-small cell carcinomag 22 14719 46 11919 45 1909 55 765 39 56 51 929 47

Other specified carcinomash 26 17437 55 14873 57 1650 47 776 39 46 42 1381 70

Carcinoma NOSi 14 9379 29 7569 29 1192 34 514 26 50 46 670 34

Sarcomaj 01 496 02 413 02 47 01 30 02 - - 68 03

Other specified typesk 00 269 01 217 01 34 01 16 01 - - 28 01

Total 479 319847 1000 262480 1000 34971 1000 19813 1000 1091 1000 19813 1000

Table 1528

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Both Sexes by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 29: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 540 161700 997 130845 997 18645 998 10935 998 521 998 10085 995

Small cell (80028041-8045) 63 19443 120 16658 127 1693 91 952 87 77 148 1051 104

Non-small cell 460 137085 846 110067 839 16269 871 9672 882 416 797 8664 855

Squamous and 149 44189 273 36643 279 5052 270 2118 193 184 352 2363 233

transitional celld

Adenocarcinomae 249 74619 460 58655 447 8949 479 6477 591 172 330 5079 501

Large cellf 08 2357 15 1862 14 353 19 128 12 - - 137 14

Non-small cell carcinomag 28 8320 51 6580 50 1151 62 517 47 34 65 497 49

Other specified carcinomash 25 7600 47 6327 48 764 41 432 39 23 44 588 58

Carcinoma NOSi 18 5172 32 4120 31 683 37 311 28 28 54 370 37

Sarcomaj 01 297 02 252 02 24 01 17 02 - - 35 03

Other specified typesk 00 133 01 104 01 20 01 - - - - - -

Total 542 162130 1000 131201 1000 18689 1000 10960 1000 522 1000 10131 1000

Table 1529

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Males by Race

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 30: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding

a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives

Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310

8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430

8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895

8900-8902 8910 8920-8921 8940 8990 9040-9041 9043 9120 9130 9133 9150 9180 9220 9231 9240 9251 9473 95409560 9580

k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530

Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581

- Statistic not shown due to fewer than 16 cases during the time period

AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc

Histologya Rate Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent

Carcinoma 431 157382 998 131005 998 16245 998 8832 998 568 998 9632 995

Small cell (80028041-8045) 56 20525 130 18293 139 1716 105 383 43 76 134 978 101

Non-small cell 364 132650 841 109263 832 14020 861 8246 931 470 826 8354 863

Squamous and 77 28016 178 23805 181 3195 196 758 86 142 250 1455 150

transitional celld

Adenocarcinomae 237 86605 549 70074 534 8951 550 6841 773 278 489 5585 577

Large cellf 05 1793 11 1499 11 230 14 55 06 - - 89 09

Non-small cell carcinomag 18 6399 41 5339 41 758 47 248 28 22 39 432 45

Other specified carcinomash 27 9837 62 8546 65 886 54 344 39 23 40 793 82

Carcinoma NOSi 11 4207 27 3449 26 509 31 203 23 22 39 300 31

Sarcomaj 01 199 01 161 01 23 01 - - - - 33 03

Other specified typesk 00 136 01 113 01 - - - - - - 17 02

Total 432 157717 1000 131279 1000 16282 1000 8853 1000 569 1000 9682 1000

Table 1530

Cancer of the Lung and Bronchus (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2013-2017Females by Race

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 31: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

0

30

60

90

120

150

180

1975 1985 1995 2005 20170

30

60

90

120

150

180

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex

a

Figure 151

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2007-17 = -26Observed 2008-17 = -29

US Mortality APC2013-17 = -47

SEER Incidence APCsDelay Adj 1998-17 = -29Observed 1998-17 = -30

US Mortality APC2013-17 = -57

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -16

US Mortality APC2014-17 = -40

SEER Incidence APCsDelay Adj 2006-17 = -19Observed 2006-17 = -21

US Mortality APC2013-17 = -45

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 32: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

0

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 20170

20

40

60

80

100

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex

a

Figure 152

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2010-17 = -24Observed 1987-17 = -34

US Mortality APC2015-17 = -66

SEER Incidence APCsDelay Adj 2003-17 = -50Observed 2003-17 = -50

US Mortality APC2015-17 = -100

SEER Incidence APCsDelay Adj 2012-17 = -03Observed 2012-17 = -06

US Mortality APC2015-17 = -48

SEER Incidence APCsDelay Adj 2005-17 = -30Observed 2005-17 = -31

US Mortality APC2014-17 = -63

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 33: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

0

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

500

600

700

800

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 20170

100

200

300

400

1975 1985 1995 2005 2017

Delay-Adj IncidenceDelay-Adj Incidence

Observed IncidenceObserved Incidence

MortalityMortality

SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex

a

Figure 153

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)

a

White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000

Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath

SEER Incidence APCsDelay Adj 2008-17 = -26Observed 2009-17 = -30

US Mortality APC2012-17 = -44 SEER Incidence APCs

Delay Adj 1997-17 = -21Observed 1997-17 = -22

US Mortality APC2012-17 = -47

SEER Incidence APCsDelay Adj 2007-17 = -14Observed 2007-17 = -15

US Mortality APC2015-17 = -45

SEER Incidence APCsDelay Adj 2006-17 = -15Observed 2006-17 = -16

US Mortality APC2013-17 = -42

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 34: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

Joinpoint Analyses for Whites and Blacks from 1975-2017and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2017

0

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 20170

10

20

30

40

50

60

70

80

90

100

1975 1985 1995 2005 2017

White

Black

API

AIAN

Hispanic

SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes

Figure 154

Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2017 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2017 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry

Incidence MortalityRate per 100000 Rate per 100000

Year of Diagnosis Year of Death

a

d

a

b

c

c

b

d

SEE

R C

ancer Statistics Review

1975-2017N

ational Cancer Institute

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 35: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

0

20

40

60

80

100

120

1975 1980 1985 1990 1995 2000 2005 2010 2017

Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence

Male MortalityMale Mortality

Female Delay-Adjusted IncidenceFemale Delay-Adjusted Incidence

Female MortalityFemale Mortality

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates

1975-2017 All Races By Sex

Figure 155

Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of DiagnosisDeath

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 36: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

0

20

40

60

80

100

120

140

160

180

1975 1980 1985 1990 1995 2000 2005 2010 2017

Black Male

White Male

Black Female

White Female

Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2017

By Sex and Race

Figure 156

Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 48 April 2020National Cancer Institute

Rate per 100000

Year of Diagnosis

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival
Page 37: SEER Cancer Statistics Review 1975-2017 · 2020-04-14 · SEER Cancer Statistics Review 1975-2017 National Cancer Institute Individual rates for diagnosis years 1975-1979 available

Figure 157

Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and

95 Confidence Intervals

Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error

0

20

40

60

80

100Percent Surviving Next 5 Years

Stage at Diagnosis

Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years

2000-2015 by stage at diagnosis

Survival Time Since Diagnosis

Localized Regional Distant Unstaged

0 year (at diagnosis) 1 year 3 years

SEER Cancer Statistics Review 1975-2017 National Cancer Institute

  • Trends in SEER Incidence and US Mortality Both Sexes
  • Trends in SEER Incidence and US Mortality Males
  • Trends in SEER Incidence and US Mortality Females
  • Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
  • Annual Delay-adjusted Incidence Rates
  • Annual Incidence Rates
  • Annual Incidence Rates (Small Cell Cancer)
  • Annual Incidence Rates (Non-Small Cell Cancer)
  • Annual Death Rates
  • Incidence and Mortality Rates by Age
  • Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
  • 5-year Relative and Period Survival
  • 5-year Relative and Period Survival (Small Cell Cancer)
  • 5-year Relative and Period Survival (Non-Small Cell Cancer)
  • Relative Survival by Year of Diagnosis Both Sexes
  • Relative Survival by Year of Diagnosis Males
  • Relative Survival by Year of Diagnosis Females
  • Risk of DevelopingDying Both Sexes
  • Risk of DevelopingDying Males
  • Risk of DevelopingDying Females
  • Rates and Trends by RaceEthnicity
  • Age-Adjusted SEER Incidence Rates by Registry
  • Age-Adjusted SEER Death Rates by Registry
  • Age-Adjusted Cancer Death Rates By State Both Sexes
  • Age-Adjusted Cancer Death Rates By State Males
  • Age-Adjusted Cancer Death Rates By State Females
  • US Prevalence Estimates
  • Case Distribution by Histology Both Sexes
  • Case Distribution by Histology Males
  • Case Distribution by Histology Females
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
  • Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
  • Graph - SEER Incidence and US Death Rates by RaceEthnicity
  • Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
  • Graph - SEER Delay Adjusted Incidence by Sex and Race
  • Graph - 5-Year SEER Conditional Relative Survival